Interleuken-23 Inhibitor Biologics

Recent research indicates that Interleuken-23 may be a primary driver for IBD and particular effective for difficult cases (see: https://www.docwirenews.com/post/targeting-il-23-a-new-era-for-inflammatory-bowel-disease-management). Have you had success controlling symptoms with an IL-23? Please feel free to share!